[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"rejection-acute-hepatic\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:rejection-acute-hepatic":39},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":13,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":5},"100500203",false,"NCT05793203","Single-center Prospective Study of Non-invasive Methods for the Diagnosis of Postoperative Complications in Liver Transplant Recipients","ElastOLT","Inclusion Criteria:\n\n* Patients eligible for liver transplantation following National and International Guidelines\n\nExclusion Criteria:\n\n* No agreement or inability to give informed consent\n\n  * Re-transplant patients\n  * Liver transplant in fulminant hepatitis","ALL","18 Years","75 Years",{"count":19,"type":20},100,"ESTIMATED","OBSERVATIONAL","A lot of different early and late complications may occur after liver transplantation. They could be related to surgical procedure, to infectious diseases or immuno-mediated diseases (acute cellular rejection, ACR). Almost all of those complications are characterized by an elevation in liver enzymes (ALT, AST and GGT) and a decline of liver function tests (serum bilirubin and INR increase) possibly leading to early allograft disfunction (EAD). In this scenario there is a lack of biomarker that could predict the development of ACR and\u002For EAD.\n\nThe aim of this study is to explore the prognostic role of non-invasive instrumental and biological marker in the early post-transplant phase.",[24,25,26],"Rejection Acute Hepatic","Transplant; Failure, Liver","Liver Dysfunction","RECRUITING","2023-03-20",{"date":30,"type":31},"2023-03-31","ACTUAL",{"date":33,"type":31},"2020-07-06",{"date":35,"type":20},"2027-12-31",{"name":37,"class":38},"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","OTHER",""]